Zurcher Kantonalbank (Zurich Cantonalbank) Sorrento Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$0.74 - $1.83 $46 - $115	-63 Reduced 0.13%	48,865 $43,000
Q3 2022 Nov 09, 2022	SELL	$1.51 - $2.88 $232 - $443	-154 Reduced 0.31%	48,928 $77,000
Q2 2022 Aug 09, 2022	SELL	$1.24 - $2.33 $1,850 - $3,476	-1,492 Reduced 2.95%	49,082 $99,000
Q1 2022 Apr 21, 2022	SELL	$2.0 - $4.9 $300 - $735	-150 Reduced 0.3%	50,574 $118,000
Q4 2021 Feb 01, 2022	BUY	$4.65 - $7.23 $40,250 - $62,582	8,656 Added 20.58%	50,724 $236,000
Q2 2021 Jul 30, 2021	BUY	$6.35 - $10.0 $5,187 - $8,170	817 Added 1.98%	42,068 $408,000
Q1 2021 May 03, 2021	BUY	$7.03 - $16.51 $85,330 - $200,398	12,138 Added 41.69%	41,251 $341,000
Q4 2020 Jan 28, 2021	BUY	$5.76 - $11.95 $65,162 - $135,190	11,313 Added 63.56%	29,113 $199,000
Q2 2020 Jul 28, 2020	BUY	$1.73 - $6.76 $30,794 - $120,328	17,800 New	17,800 $112,000
Q4 2019 Jan 21, 2020	SELL	$1.45 - $4.17 $13,000 - $37,388	-8,966 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$2.67 - $4.38 $9,961 - $16,341	3,731 Added 71.27%	8,966 $24,000
Q4 2018 Jan 25, 2019	BUY	$2.01 - $4.24 $10,522 - $22,196	5,235 New	5,235 $13,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.37M

Call Options Held

Put Options Held

B. Riley Securities, Inc. Los Angeles, CA

5.22M
Shares

$1.72 Million
1.01% of portfolio
Swisspartners Ltd. Vaduz, N2

110K
Shares

$36,300
0.12% of portfolio
Frontier Wealth Management LLC Kansas City, MO

20.5K
Shares

$6,765
0.0% of portfolio
Corient Capital Partners, LLC Newport Beach, CA

14.9K
Shares

$4,921
0.0% of portfolio
Huntington National Bank Columbus, OH

5K
Shares

$1,650
0.0% of portfolio

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account